Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Improving the information content of categorical clinical trial endpoints.

Berger VW.

Control Clin Trials. 2002 Oct;23(5):502-14.

PMID:
12392864
2.

Some issues with composite endpoints in clinical trials.

Chi GY.

Fundam Clin Pharmacol. 2005 Dec;19(6):609-19. Review.

PMID:
16313272
3.

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials.

Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, Cleeland CS, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad AR, Jay GW, Jermano JA, Katz NP, Manning DC, Martin S, Max MB, McGrath P, McQuay HJ, Quessy S, Rappaport BA, Revicki DA, Rothman M, Stauffer JW, Svensson O, White RE, Witter J.

Pain. 2008 Oct 31;139(3):485-93. doi: 10.1016/j.pain.2008.06.025. Epub 2008 Aug 15. Review.

PMID:
18706763
5.

Outcome measurement in female sexual dysfunction clinical trials: review and recommendations.

Althof SE, Rosen RC, DeRogatis L, Corty E, Quirk F, Symonds T.

J Sex Marital Ther. 2005 Mar-Apr;31(2):153-66. Review.

PMID:
15859374
6.

Statistical considerations for the next generation of clinical trials.

Wu W, Shi Q, Sargent DJ.

Semin Oncol. 2011 Aug;38(4):598-604. doi: 10.1053/j.seminoncol.2011.05.014. Review.

PMID:
21810519
7.

The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases.

Lonn E.

Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):497-508. Review.

PMID:
11828831
8.

A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials.

Molenberghs G, Burzykowski T, Alonso A, Assam P, Tilahun A, Buyse M.

Stat Methods Med Res. 2010 Jun;19(3):205-36. doi: 10.1177/0962280209105015. Epub 2009 Jul 16. Review.

PMID:
19608602
9.
10.

Novel procedures for validating surrogate endpoints in clinical trials.

Cleophas TJ, Zwinderman AH, Chaib AH.

Curr Clin Pharmacol. 2007 May;2(2):123-8. Review.

PMID:
18690859
11.

Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns.

Ferreira-González I, Permanyer-Miralda G, Busse JW, Bryant DM, Montori VM, Alonso-Coello P, Walter SD, Guyatt GH.

J Clin Epidemiol. 2007 Jul;60(7):651-7; discussion 658-62. Epub 2007 Feb 23. Review.

PMID:
17573977
12.

[Composite endpoints in clinical trials].

Ferreira-González I, Alonso-Coello P, Solà I, Pacheco-Huergo V, Domingo-Salvany A, Alonso J, Montori V, Permanyer-Miralda G.

Rev Esp Cardiol. 2008 Mar;61(3):283-90. Review. Spanish.

13.

Design and endpoints of clinical trials in hepatocellular carcinoma.

Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of Experts in HCC-Design Clinical Trials.

J Natl Cancer Inst. 2008 May 21;100(10):698-711. doi: 10.1093/jnci/djn134. Epub 2008 May 13. Review.

PMID:
18477802
14.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
15.

Endpoints for assessing drug activity in clinical trials.

Pazdur R.

Oncologist. 2008;13 Suppl 2:19-21. doi: 10.1634/theoncologist.13-S2-19. Review.

16.

Efficacy and other milestones for human papillomavirus vaccine introduction.

Pagliusi SR, Teresa Aguado M.

Vaccine. 2004 Dec 16;23(5):569-78. Review.

PMID:
15630792
17.

Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.

Willke RJ, Burke LB, Erickson P.

Control Clin Trials. 2004 Dec;25(6):535-52. Review.

PMID:
15588741
18.

Statistical challenges in the evaluation of surrogate endpoints in randomized trials.

Molenberghs G, Buyse M, Geys H, Renard D, Burzykowski T, Alonso A.

Control Clin Trials. 2002 Dec;23(6):607-25. Review.

PMID:
12505240
19.
20.

Endpoints in respiratory diseases.

de Benedictis FM, Guidi R, Carraro S, Baraldi E; TEDDY European Network of Excellence.

Eur J Clin Pharmacol. 2011 May;67 Suppl 1:49-59. doi: 10.1007/s00228-010-0922-2. Epub 2010 Nov 23. Review.

PMID:
21104409

Supplemental Content

Support Center